Bristol-Myers Squibb vs Medtronic
Bristol-Myers Squibb (BMY), health care, and Medtronic (MDT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Medtronic is worth $132.1B on the stock market and Bristol-Myers Squibb $124.7B: Medtronic is valued at 6% more. Bristol-Myers Squibb trades at 13.5 times earnings and Medtronic at 25.4. Over the past year Bristol-Myers Squibb's share price has moved +33.7% and Medtronic's +2.06%.
Key facts
- Bristol-Myers Squibb market value
- $124.7B
- Medtronic market value
- $132.1B
- Bristol-Myers Squibb P/E
- 13.5
- Medtronic P/E
- 25.4
- Bristol-Myers Squibb revenue
- $48.2BFY to 2025-12-31
- Medtronic revenue
- $36.4BFY to 2026-04-24
- Superinvestors holding both
- 3
Market values as of .
| Measure | Bristol-Myers Squibb | Medtronic |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2026-04-24 |
| Size | ||
| Market cap | $124.7Blower | $132.1Bhigher |
| Revenue | $48.2Bhigher | $36.4Blower |
| Earnings | $7.1Bhigher | $4.8Blower |
| Employees | 32,500lower | 95,000higher |
| Total assets | $90Blower | $93Bhigher |
| Valuation | ||
| P/E | 13.5lower | 25.4higher |
| P/S | 2.6lower | 3.6higher |
| P/B | 5.3 | — |
| Dividend yield | 4.00% | — |
| Profitability | ||
| Operating margin | — | 17.8% |
| Balance sheet | ||
| Net assets | $18.5Blower | $49.5Bhigher |
| Total liabilities | $71.5Bhigher | $43Blower |
| Total debt | $45.1Bhigher | $28Blower |
| Cash on hand | $10.2Bhigher | $1.9Blower |
| Price change | ||
| Today | -3.08%lower | +0.38%higher |
| 1 year | +33.7%higher | +2.06%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (3)
- Richard Pzena2.6% / 0.8%
- Mark Boyar0.5% / 0.4%
- Mairs & Power team<0.1% / 0.3%
Bristol-Myers Squibb only (12)
Medtronic only (7)
Percentages are each holding's share of that investor's reported portfolio (under "Both": Bristol-Myers Squibb / Medtronic). Who owns BMY · Who owns MDT
More on Bristol-Myers Squibb
Further comparisons
Bristol-Myers Squibb against its closest peers
Medtronic against its closest peers
Learn
Questions and answers
Which is bigger, Bristol-Myers Squibb or Medtronic?
By market value, Medtronic is the larger: $132.1B against $124.7B for Bristol-Myers Squibb. By revenue in its latest fiscal year, Bristol-Myers Squibb is the larger: $48.2B against $36.4B for Medtronic.
Which has the higher P/E ratio?
Medtronic: 25.4, against 13.5 for Bristol-Myers Squibb. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has more debt?
Bristol-Myers Squibb: $45.1B, against $28B for Medtronic. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Bristol-Myers Squibb and Medtronic?
In their latest 13F filings, Richard Pzena, Mark Boyar and Mairs & Power team hold both.
Cite this page
Funkfolio, “Bristol-Myers Squibb vs Medtronic”, data as of 17 November 2026. https://funkfolio.com/compare/bmy-vs-mdt
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.